NCT06613321View on ClinicalTrials.gov

Lung Hyperinflation and Response to Pulmonary Vasodilator Therapy

CompletedOBSERVATIONAL
Enrollment

47

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

March 25, 2024

Study Completion Date

March 25, 2024

Conditions
CopdHypertension, PulmonaryHyperdistention
Interventions
DIAGNOSTIC_TEST

Respiratory function tests before introduction of vasodilator therapy

Respiratory function tests before introduction of vasodilator therapy with evaluation of the RV/TLC ratio.

DIAGNOSTIC_TEST

3 month follow up evaluation of response to treatment.

Follow up of patients at least 3 months after introduction of vasodilator therapy to determine response to treatment or absence of response.

Trial Locations (1)

54500

CHU Nancy, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER